NASDAQ:EVFM

Evofem Biosciences Earning Date

USA |NASDAQ |USD

EVFM Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 8, 2021 Sep 2021 $-0.29 $-0.27 $-0.37
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 8, 2021 Sep 2021 $3.39M $1.86M $278.00K

Evofem Biosciences's next earnings date is Monday, Nov 8, 2021 for the fiscal quarter ending Sep 2021.

EVFM Earnings Date & History Chart

EVFM Earnings & Revenue Forecast

EVFM Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 4 $-0.35 $-0.56 $-0.26
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 4 $-1.39 $-1.61 $-1.24
Dec 2022 4 $-0.72 $-0.92 $-0.50

EVFM Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 1 $-0.38 $-0.34 $-0.38
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 1 / 0 $-1.45 $-1.41 $-1.65
Dec 2022 1 / 0 $-0.80 $-0.78 $-0.96

EVFM Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 3 $5.76M $3.60M $8.28M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 4 $11.39M $8.81M $15.85M
Dec 2022 4 $50.13M $28.16M $79.28M

EVFM Earnings Date & Revenue History

EVFM Earnings History

|
Show More
Show More

EVFM Revenue History

|
Show More
Show More

Evofem Biosciences Next Earnings Date & Report

EVFM Next Earnings Date & Report Preview: Sep 2021 (FQ)

EVFM's next earnings date is Monday, Nov 8, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 4 analysts, the average EPS estimation for Evofem Biosciences's next quarterly earnings is $-0.29, with a low EPS estimation of $-0.33, and a high estimation of $-0.26.

Over the last 1 month, EPS estimates have seen 1 upward revisions and 0 downward. The EPS 1 month trend is $-0.31, the last 2 month trend is $-0.30, and the 3 month trend is $-0.38.

Based on 2 analysts, the average revenue estimation is $3.39M, with a low revenue estimation of $2.25M, and a high estimation of $4.61M.

Evofem Biosciences Previous Earnings Dates & Reports

EVFM Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Evofem Biosciences's previous earnings date was Aug 11, 2021 for its fiscal quarter ended Jun 30, 2021.

EVFM's earnings per share (EPS) was $-0.27, beating the consensus analysts forecast of $-0.35 by 23.40%.

The EPS was higher than the previous fiscal quarter (Mar 2021) by -51.79%, and higher than the same period a year before (Jun 2020) by -70.33%.

Revenues were $1.86M.

The company reported a net income of $-33.43M.

Free cash flow for the quarter was $-54.91M , compared to $-35.41M last quarter and $-15.49M a year before.

EVFM ended the quarter with $78.14M in total debt, a decrease of -10.15% compared to the previous quarter, and an increase of 57.69% compared to the same quarter a year before.

EVFM Previous Earnings Date & Report Recap: Dec 2020 (FY)

Evofem Biosciences's previous annual earnings date was Mar 4, 2021 for its fiscal year ended Dec 31, 2020.

EVFM's earnings per share (EPS) was $-2.17, missing the consensus analysts forecast of $-1.93 by 12.44% , and higher than the previous year's EPS (Dec 2019) by -1.81%.

Revenues were $446.00K.

The company reported a net income of $-142.31M.

Evofem Biosciences reported a free cash flow of $-107.08M for its fiscal year, compared to $-55.26M a year ago.

The company ended the fiscal year with $79.91M in total debt, an increase of 40463.45% compared to the previous year.